Skip to main content

Market Overview

20 Stocks Moving In Monday's Pre-Market Session

Share:

Gainers

  • Westport Fuel Systems Inc (USA) (NASDAQ: WPRT) rose 34 percent to $1.42 in pre-market trading after the company reported the signing of a definitive agreement to sell its APU assets for $70 million.
  • Alere Inc (NYSE: ALR) rose 17 percent to $49.50 in pre-market trading. Abbott Laboratories (NYSE: ABT) agreed to buy Alere for $51 per share, versus its earlier offer of $56 per share.
  • Immune Pharmaceuticals Inc (NASDAQ: IMNP) shares rose 16.5 percent to $2.97 in pre-market trading after declining 2.67 percent on Thursday.
  • HTG Molecular Diagnostics Inc (NASDAQ: HTGM) rose 11.9 percent to $6.50 in pre-market trading on announcement that the company and Daiichi Sankyo have completed a master services agreement.
  • Catalyst Biosciences Inc (NASDAQ: CBIO) rose 10.2 percent to $5.96 in pre-market trading after climbing 2.46 percent on Thursday.
  • Moneygram International Inc (NASDAQ: MGI) rose 9.1 percent to $18.00 in pre-market trading after China's Ant Financial raised its bid for the company by 36 percent to $18 per share in cash.
  • Cameco Corp (USA) (NYSE: CCJ) rose 7.1 percent to $11.90 in pre-market trading after dropping 1.94 percent on Thursday.
  • Straight Path Communications Inc (NYSE: STRP) rose 7 percent to $98.10 in pre-market trading after falling 0.33 percent on Thursday. A report on Thursday mentioned that Verizon could top AT&T bid.
  • Norsat International Inc (USA) (NYSE: NSAT) shares rose 6.4 percent to $10.75 in pre-market trading. Privet Fund Management offered US$11 per share to acquire Norsat International.
  • Pingtan Marine Enterprise Ltd (NASDAQ: PME) shares rose 5.4 percent to $4.90 in pre-market trading after gaining 5.92 percent on Thursday.
  • Nutanix Inc (NASDAQ: NTNX) rose 4.6 percent to $18.00 in pre-market trading after dropping 2.71 percent on Thursday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • GWG Holdings Inc (NASDAQ: GWGH) fell 19.4 percent to $8.45 in pre-market trading after dropping 5.62 percent on Thursday.
  • Incyte Corporation (NASDAQ: INCY) fell 10.9 percent to $125.50 in pre-market trading. The FDA on Friday declined to approve Eli Lilly and Co and Incyte arthritis drug Olumiant. PiperJaffray downgraded Incyte from Overweight to Neutral.
  • Baxter International Inc (NYSE: BAX) shares fell 9.9 percent to $48.00 in the pre-market trading session. Baxter disclosed that one of its employees received a DoJ grand jury subpoena pursuant to criminal investigation.
  • Patheon NV (NYSE: PTHN) fell 9.8 percent to $23.26 in pre-market trading after dropping 1.04 percent on Thursday.
  • Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) fell 8.3 percent to $14.68 in pre-market trading. Chardan Capital reiterated Akari Therapeutics with a Sell and raised the price target from $5.00 to $6.50.
  • RH (NYSE: RH) shares fell 6.3 percent to $44.05 in pre-market trading after slipping 0.02 percent on Thursday.
  • SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) shares fell 5.7 percent to $9.05 in pre-market trading after dropping 1.03 percent on Thursday.
  • Eli Lilly and Co (NYSE: LLY) fell 5.2 percent to $81.41 in pre-market trading. The FDA on Friday declined to approve Eli Lilly and Incyte arthritis drug Olumiant. BMO Capital downgraded Eli Lilly from Market Perform to Underperform.
  • Texas Pacific Land Trust (NYSE: TPL) dropped 5.2 percent to $263.50 in pre-market trading after declining 5.91 percent on Thursday.
 

Related Articles (ABT + AKTX)

View Comments and Join the Discussion!

Posted-In: #PreMarket Gainers LosersNews Movers & Shakers Pre-Market Outlook Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com